Ayogu, R. N., Oshomegie, H., & Udenta, E. A. (2022). Energy intake, expenditure and balance, and factors associated with energy balance of young adults (20–39 years): A retrospective cross-sectional community-based cohort study. BMC Nutrition, 8, 142.
Article PubMed Central Google Scholar
Brunt, E. M. (2012). Nonalcoholic fatty liver disease: What the pathologist can tell the clinician. Digestive Diseases, 30, 61–68.
Chung, H. J., Yu, J. G., Lee, I. A., Liu, M. J., Shen, Y. F., Sharma, S. P., Jamal, M. A., Yoo, J. H., Kim, H. J., & Hong, S. T. (2016). Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity. FEBS Open Bio, 6, 64–76.
Article CAS PubMed Central Google Scholar
Fazel, Y., Koenig, A. B., Sayiner, M., Goodman, Z. D., & Younossi, Z. M. (2016). Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism, 65, 1017–1025.
Fekete, K., Györei, E., Lohner, S., Verduci, E., Agostoni, C., & Decsi, T. (2015). Long-chain polyunsaturated fatty acid status in obesity: A systematic review and meta‐analysis. Obesity Reviews, 16, 488–497.
Ghadge, A. A., & Khaire, A. A. (2019). Leptin as a predictive marker for metabolic syndrome. Cytokine, 121, 154735.
Girona, J., Amigó, N., Ibarretxe, D., Plana, N., Rodríguez-Borjabad, C., Heras, M., Ferré, R., Gil, M., Correig, X., & Masana, L. (2019). HDL triglycerides: A new marker of metabolic and cardiovascular risk. International Journal of Molecular Sciences, 20, 3151.
Article CAS PubMed Central Google Scholar
Hariri, N., & Thibault, L. (2010). High-fat diet-induced obesity in animal models. Nutrition Research Reviews, 23, 270–299.
Hecker, J., Freijer, K., Hiligsmann, M., & Evers, S. (2022). Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life. Bmc Public Health, 22, 46.
Article CAS PubMed Central Google Scholar
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., & Salminen, S. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11, 506–514.
Huang, L., & Li, C. (2000). Leptin: A multifunctional hormone. Cell Research, 10, 81–92.
Huang, J., Borensztajn, J., & Reddy, J. K. (2011). Hepatic lipid metabolism. In S. Monga (Ed.), Molecular Pathology of Liver Diseases Molecular Pathology Library (Vol. 5, pp. 133–146). Springer.
Jeong, H., Hwang, U. S., Choi, H., Park, Y. S., CAB701. (2023). Assessing the anti-obesity potential of Lactococcus lactis subsp. lactis CAB701: Modulation of adipocyte differentiation and lipid metabolism in in vitro and in vivo models. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10198-9
Jurášková, D., Ribeiro, S. C., & Silva, C. C. (2022). Exopolysaccharides produced by lactic acid bacteria: From biosynthesis to health-promoting properties. Foods, 11, 156.
Article PubMed Central Google Scholar
Kang, J. H., Yun, S. I., Park, M. H., Park, J. H., Jeong, S. Y., & Park, H. O. (2013). Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. Plos One, 8, e54617.
Article CAS PubMed Central Google Scholar
Karimi, G., Jamaluddin, R., Mohtarrudin, N., Ahmad, Z., Khazaai, H., & Parvaneh, M. (2017). Single-species versus dual-species probiotic supplementation as an emerging therapeutic strategy for obesity. Nutrition Metabolism and Cardiovascular Diseases, 27, 910–918.
Kim, J., Yun, J. M., Kim, M. K., Kwon, O., & Cho, B. (2018). Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adAlts: a randomized, double-blind, placebo-controlled trial. Journal of Medicinal Food, 21, 454–461.
Kim, G., Bae, J. H., Cheon, S., Lee, D. H., Kim, D. H., Lee, D., Park, S. H., Shim, S., Seo, J. H., & Han, N. S. (2022). Prebiotic activities of dextran from Leuconostoc mesenteroides SPCL742 analyzed in the aspect of the human gut microbial ecosystem. Food and Function, 13, 1256–1267.
Kim, W. K., Min, S. G., Kwon, H., Park, S., Jo, M. J., & Ko, G. (2023). Lactobacillus rhamnosus KBL2290 ameliorates gut inflammation in a mouse model of dextran sulfate sodium-induced colitis. Journal of Microbiology, 61, 673–682.
Lee, J., Park, S., Oh, N., Park, J., Kwon, M., Seo, J., & Roh, S. (2021). Oral intake of Lactobacillus plantarum L-14 extract alleviates TLR2‐and AMPK‐mediated obesity‐associated disorders in high‐fat‐diet‐induced obese C57BL/6J mice. Cell Proliferation, 54, e13039.
Article CAS PubMed Central Google Scholar
Lehnert, T., Sonntag, D., Konnopka, A., Riedel-Heller, S., & König, H. H. (2012). The long‐term cost‐effectiveness of obesity prevention interventions: Systematic literature review. Obesity Reviews, 13, 537–553.
Lian, C. Y., Zhai, Z. Z., Li, Z. F., & Wang, L. (2020). High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions, 330, 109199.
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020). Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism, 111, 154170.
Marihart, C. L., Brunt, A. R., & Geraci, A. A. (2014). Older adults fighting obesity with bariatric surgery: Benefits, side effects, and outcomes. SAGE Open Medicine, 2, 2050312114530917.
Article PubMed Central Google Scholar
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022). Anti-obesity drug discovery: Advances and challenges. Nature Reviews Drug Discovery, 21, 201–223.
Oerlemans, M. M., Akkerman, R., Ferrari, M., Walvoort, M. T., & de Vos, P. (2021). Benefits of bacteria-derived exopolysaccharides on gastrointestinal microbiota, immunity and health. Journal of Functional Foods, 76, 104289.
Park, J. H., Ahn, E. K., Hwang, M. H., Park, Y. J., Cho, Y. R., Ko, H. J., Jeong, W., Yang, S. H., Seo, D. W., & Oh, J. S. (2021). Improvement of obesity and dyslipidemic activity of Amomum tsao-ko in C57BL/6 mice fed a high-carbohydrate diet. Molecules, 26, 1638.
Article CAS PubMed Central Google Scholar
Pérez-Corredor, P., Gutiérrez-Vargas, J., Ciro-Ramírez, L., Balcazar, N., & Cardona-Gómez, G. (2022). High fructose diet-induced obesity worsens post-ischemic brain injury in the hippocampus of female rats. Nutritional Neuroscience, 25, 122–136.
Sarwar, R., Pierce, N., & Koppe, S. (2018). Obesity and nonalcoholic fatty liver disease: Current perspectives. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy, 11, 533–542.
Shen, Y. L., Zhang, L. Q., Yang, Y., Yin, B. C., Ye, B. C., & Zhou, Y. (2022). Advances in the role and mechanism of lactic acid bacteria in treating obesity. Food Bioengineering, 1, 101–115.
Sinclair, P., Docherty, N., & le Roux, C. W. (2018). Metabolic effects of bariatric surgery. Clinical Chemistry, 64, 72–81.
Soleimani, M., Barone, S., Luo, H., & Zahedi, K. (2023). Pathogenesis of hypertension in metabolic syndrome: The role of fructose and salt. International Journal of Molecular Sciences, 24, 4294.
Article CAS PubMed Central Google Scholar
Stienstra, R., Duval, C., Müller, M., & Kersten, S. (2007). PPARs, obesity, and inflammation. PPAR Research, 2007, 95974.
Szulińska, M., Łoniewski, I., van Hemert, S., Sobieska, M., & Bogdański, P. (2018). Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in obese postmenopausal women: A 12-week randomized clinical trial. Nutrients, 10, 773.
Article PubMed Central Google Scholar
Tappy, L., & Lê, K. A. (2010). Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews, 90, 23–46.
Todoric, J., Di Caro, G., Reibe, S., Henstridge, D. C., Green, C. R., Vrbanac, A., Ceteci, F., Conche, C., McNulty, R., Shalapour, S., et al. (2020). Fructose stimulated de novo lipogenesis is promoted by inflammation. Nature Metabolism, 2, 1034–1045.
留言 (0)